These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 32762714)

  • 1. The functional epigenetic landscape of aberrant gene expression in molecular subgroups of newly diagnosed multiple myeloma.
    Choudhury SR; Ashby C; Tytarenko R; Bauer M; Wang Y; Deshpande S; Den J; Schinke C; Zangari M; Thanendrarajan S; Davies FE; van Rhee F; Morgan GJ; Walker BA
    J Hematol Oncol; 2020 Aug; 13(1):108. PubMed ID: 32762714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia.
    Kushwaha G; Dozmorov M; Wren JD; Qiu J; Shi H; Xu D
    Hum Genomics; 2016 Jul; 10 Suppl 2(Suppl 2):18. PubMed ID: 27461342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromatin-based, in cis and in trans regulatory rewiring underpins distinct oncogenic transcriptomes in multiple myeloma.
    Alvarez-Benayas J; Trasanidis N; Katsarou A; Ponnusamy K; Chaidos A; May PC; Xiao X; Bua M; Atta M; Roberts IAG; Auner HW; Hatjiharissi E; Papaioannou M; Caputo VS; Sudbery IM; Karadimitris A
    Nat Commun; 2021 Sep; 12(1):5450. PubMed ID: 34521827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new multiple myeloma cell line, MEF-1, possesses cyclin D1 overexpression and the p53 mutation.
    Yufu Y; Goto T; Choi I; Uike N; Kozuru M; Ohshima K; Taniguchi T; Motokura T; Yatabe Y; Nakamura S
    Cancer; 1999 Apr; 85(8):1750-7. PubMed ID: 10223569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers.
    Agirre X; Castellano G; Pascual M; Heath S; Kulis M; Segura V; Bergmann A; Esteve A; Merkel A; Raineri E; Agueda L; Blanc J; Richardson D; Clarke L; Datta A; Russiñol N; Queirós AC; Beekman R; Rodríguez-Madoz JR; San José-Enériz E; Fang F; Gutiérrez NC; García-Verdugo JM; Robson MI; Schirmer EC; Guruceaga E; Martens JH; Gut M; Calasanz MJ; Flicek P; Siebert R; Campo E; Miguel JF; Melnick A; Stunnenberg HG; Gut IG; Prosper F; Martín-Subero JI
    Genome Res; 2015 Apr; 25(4):478-87. PubMed ID: 25644835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA hydroxymethylation is associated with disease severity and persists at enhancers of oncogenic regions in multiple myeloma.
    Alberge JB; Magrangeas F; Wagner M; Denié S; Guérin-Charbonnel C; Campion L; Attal M; Avet-Loiseau H; Carell T; Moreau P; Minvielle S; Sérandour AA
    Clin Epigenetics; 2020 Nov; 12(1):163. PubMed ID: 33138842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses.
    Fabris S; Agnelli L; Mattioli M; Baldini L; Ronchetti D; Morabito F; Verdelli D; Nobili L; Intini D; Callea V; Stelitano C; Lombardi L; Neri A
    Genes Chromosomes Cancer; 2005 Feb; 42(2):117-27. PubMed ID: 15543617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation regulates discrimination of enhancers from promoters through a H3K4me1-H3K4me3 seesaw mechanism.
    Sharifi-Zarchi A; Gerovska D; Adachi K; Totonchi M; Pezeshk H; Taft RJ; Schöler HR; Chitsaz H; Sadeghi M; Baharvand H; Araúzo-Bravo MJ
    BMC Genomics; 2017 Dec; 18(1):964. PubMed ID: 29233090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-transcriptional Modifications Contribute to the Upregulation of Cyclin D2 in Multiple Myeloma.
    Misiewicz-Krzeminska I; Sarasquete ME; Vicente-Dueñas C; Krzeminski P; Wiktorska K; Corchete LA; Quwaider D; Rojas EA; Corral R; Martín AA; Escalante F; Bárez A; García JL; Sánchez-García I; García-Sanz R; San Miguel JF; Gutiérrez NC
    Clin Cancer Res; 2016 Jan; 22(1):207-17. PubMed ID: 26341922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive characterization of the epigenetic landscape in Multiple Myeloma.
    Alaterre E; Ovejero S; Herviou L; de Boussac H; Papadopoulos G; Kulis M; Boireau S; Robert N; Requirand G; Bruyer A; Cartron G; Vincent L; Martinez AM; Martin-Subero JI; Cavalli G; Moreaux J
    Theranostics; 2022; 12(4):1715-1729. PubMed ID: 35198065
    [No Abstract]   [Full Text] [Related]  

  • 11. Occurrence of dysregulated oncogenes in primary plasma cells representing consecutive stages of myeloma pathogenesis: indications for different disease entities.
    Rasmussen T; Theilgaard-Mönch K; Hudlebusch HR; Lodahl M; Johnsen HE; Dahl IM
    Br J Haematol; 2003 Oct; 123(2):253-62. PubMed ID: 14531906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 gene activation in human myeloma cells is independent of DNA hypomethylation or histone hyperacetylation.
    Krieger S; Grunau C; Sabbah M; Sola B
    Exp Hematol; 2005 Jun; 33(6):652-9. PubMed ID: 15911089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts.
    Chesi M; Nardini E; Lim RS; Smith KD; Kuehl WM; Bergsagel PL
    Blood; 1998 Nov; 92(9):3025-34. PubMed ID: 9787135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin D1 activation in B-cell malignancy: association with changes in histone acetylation, DNA methylation, and RNA polymerase II binding to both promoter and distal sequences.
    Liu H; Wang J; Epner EM
    Blood; 2004 Oct; 104(8):2505-13. PubMed ID: 15226187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide DNA methylation profiling in the superior temporal gyrus reveals epigenetic signatures associated with Alzheimer's disease.
    Watson CT; Roussos P; Garg P; Ho DJ; Azam N; Katsel PL; Haroutunian V; Sharp AJ
    Genome Med; 2016 Jan; 8(1):5. PubMed ID: 26803900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors.
    Avet-Loiseau H; Gerson F; Magrangeas F; Minvielle S; Harousseau JL; Bataille R;
    Blood; 2001 Nov; 98(10):3082-6. PubMed ID: 11698294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cord blood DNA methylome in newborns later diagnosed with autism spectrum disorder reflects early dysregulation of neurodevelopmental and X-linked genes.
    Mordaunt CE; Jianu JM; Laufer BI; Zhu Y; Hwang H; Dunaway KW; Bakulski KM; Feinberg JI; Volk HE; Lyall K; Croen LA; Newschaffer CJ; Ozonoff S; Hertz-Picciotto I; Fallin MD; Schmidt RJ; LaSalle JM
    Genome Med; 2020 Oct; 12(1):88. PubMed ID: 33054850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells.
    Martinez-Garcia E; Popovic R; Min DJ; Sweet SM; Thomas PM; Zamdborg L; Heffner A; Will C; Lamy L; Staudt LM; Levens DL; Kelleher NL; Licht JD
    Blood; 2011 Jan; 117(1):211-20. PubMed ID: 20974671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated analysis of DNA methylation profiling and gene expression profiling identifies novel markers in lung cancer in Xuanwei, China.
    Wang J; Duan Y; Meng QH; Gong R; Guo C; Zhao Y; Zhang Y
    PLoS One; 2018; 13(10):e0203155. PubMed ID: 30286088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of mutations in DNA methylation modification genes on genome-wide methylation landscapes and downstream gene activations in pan-cancer.
    Lee CJ; Ahn H; Jeong D; Pak M; Moon JH; Kim S
    BMC Med Genomics; 2020 Feb; 13(Suppl 3):27. PubMed ID: 32093698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.